Orphan Drugs: Are They Losing Their Sparkle?

On Demand Webinar

Orphan Drugs: Are They Losing Their Sparkle?

For ten years, orphan drugs have doubled their market share in global prescription drug sales, surpassing non-orphan drugs.

However, their once bright gloss is beginning to dull, and their growth advantage is diminishing.

Watch now

I would like to receive Evaluate industry & market reports, and the latest news from Evaluate. エバリュエートの業界・市場レポートやイベント等最新ニュースを受け取る（無料）

Connect with our advisory team
Get insights on BD&L, portfolio, and competitive intelligence 業界特化型コンサルタントとの個別相談を希望する
BD&L／ポートフォリオ／競合インテリジェンスについて、担当者よりご連絡いたします

Your information will be used in accordance with our Privacy notice. ご提供いただいた情報は、当社のプライバシー通知に基づき適切に取り扱います。

About this webinar

Get expert insights on:

Major players in the field
Exciting therapy areas
Technologies primed to drive growth
Rare diseases’ significance for big pharma
What’s piquing investors’ interest?
The impact of new legislation on R&D pipelines

Watch our to discover the reasons behind this shift and what the future may hold.

Core Forecasting Products

Regional Forecasts

Forecast Enablement

Bespoke Forecasting

Portfolio & Scenario Analysis

Competitive Context

Pipeline & Asset Intelligence

Deal and Asset Evaluation

Bespoke Business Development Analysis

Scientific & Pipeline Intelligence

Competitive Intelligence Platforms

Epidemiology Context

Market and Company Benchmarks

Custom Solutions

Support

Training and Enablement

Need Help?

Forecasting

Business Development & Licensing

Portfolio Strategy

Competitive Intelligence

Discover Resources

On Demand Webinar